药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzylpenicilloyl polylysine
Cobimetinib
The excretion of Cobimetinib can be decreased when combined with Bezafibrate.
Benzylpenicilloyl polylysine
Liotrix
The excretion of Liotrix can be decreased when combined with Bezafibrate.
Benzylpenicilloyl polylysine
Pitolisant
The serum concentration of Bezafibrate can be decreased when it is combined with Pitolisant.
Benzylpenicilloyl polylysine
Diphenadione
The risk or severity of bleeding can be increased when Bezafibrate is combined with Diphenadione.
Benzylpenicilloyl polylysine
Clorindione
The risk or severity of bleeding can be increased when Bezafibrate is combined with Clorindione.
Benzylpenicilloyl polylysine
Fluindione
The risk or severity of bleeding can be increased when Bezafibrate is combined with Fluindione.
Benzylpenicilloyl polylysine
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Bezafibrate is combined with Ethyl biscoumacetate.
Benzylpenicilloyl polylysine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Bezafibrate is combined with 4-hydroxycoumarin.
Benzylpenicilloyl polylysine
Acenocoumarol
The risk or severity of bleeding can be increased when Bezafibrate is combined with Acenocoumarol.
Benzylpenicilloyl polylysine
(S)-Warfarin
The risk or severity of bleeding can be increased when Bezafibrate is combined with (S)-Warfarin.
Benzylpenicilloyl polylysine
Tioclomarol
The risk or severity of bleeding can be increased when Bezafibrate is combined with Tioclomarol.
Benzylpenicilloyl polylysine
(R)-warfarin
The risk or severity of bleeding can be increased when Bezafibrate is combined with (R)-warfarin.
Benzylpenicilloyl polylysine
Coumarin
The risk or severity of bleeding can be increased when Bezafibrate is combined with Coumarin.
Benzylpenicilloyl polylysine
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Bezafibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Benzylpenicilloyl polylysine
Colesevelam
Colesevelam can cause a decrease in the absorption of Bezafibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Benzylpenicilloyl polylysine
Metahexamide
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Metahexamide.
Benzylpenicilloyl polylysine
Carbutamide
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Carbutamide.
Benzylpenicilloyl polylysine
Glibornuride
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glibornuride.
Benzylpenicilloyl polylysine
Glisoxepide
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glisoxepide.
Benzylpenicilloyl polylysine
Gliquidone
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Gliquidone.